The performance of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent expiration in key territories has introduced substantial uncertainty . Investors are now facing the impact of generic co